Serial thyroid iodine content in hyperthyroid patients treated with radioiodine.
X-ray fluorescent scanning was used to measure initial thyroidal iodine content in 64 patients diagnosed as being hyperthyroid and selected for I-131 therapy, and serially in 48 of these patients after therapy in an attempt to determine those patients that were at high risk of becoming hypothyroid. Iodine content fell rapidly after therapy, reaching a nadir at about three months. Based on the population studied, the chance of early hypothyroidism (within 12 months) is about 80% if the iodine content measured at three months is less than 2 mg. If the iodine content is greater than 2 mg, the chance is only about 14%. The serial measurement of thyroidal iodine content (with x-ray fluorescent scanning) may allow early identification of those patients at high risk of developing permanent hypothyroidism following a therapeutic dose of I-131.
D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism / Q000532:radiotherapy*; D007037:Hypothyroidism / Q000209:etiology; D007455:Iodine / Q000032:analysis*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013961:Thyroid Gland / Q000032:analysis*
D007457:Iodine Radioisotopes; D007455:Iodine